The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 179.00
Bid: 178.50
Ask: 187.50
Change: 1.00 (0.56%)
Spread: 9.00 (5.042%)
Open: 187.50
High: 187.50
Low: 178.50
Prev. Close: 178.00
NXR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of AGM

19 Jul 2022 14:05

RNS Number : 0160T
Norcros PLC
19 July 2022
 

Norcros plc

("Norcros", the "Group" or the "Company")

Results of AGM

Following the Annual General Meeting held on 19 July 2022, Norcros plc announces the results of the poll vote for each resolution as follows:

 

Annual General Meeting Resolutions numbered as per Notice of Meeting

For*

Against

Withheld

Number

%

Number

%

Number

Ordinary Resolutions

1

To receive the audited accounts and the auditor's and Directors' reports for the year ended 31 March 2022

74,107,414

 

99.71

 

216,569

 

0.29%

 

11,239

 

2

To declare a final dividend of 6.9 pence per ordinary share for the year ended 31 March 2022.

74,335,222

 

100.00

 

0

 

0.00%

 

0

 

3

To approve the Directors' Remuneration Report for the year ended 31 March 2022

59,638,491

 

80.24

 

14,686,840

 

19.76

 

9891

 

4

To elect Gary Kennedy as a director

74,026,555

 

99.61

 

292,428

 

0.39

 

16,239

 

5

To re-elect Alison Littley as a director

70,881,022

95.37

3,438,950

4.63

15,250

6

To re-elect David McKeith as director

72,196,671

98.09

1,408,921

1.91

729,630

7

To re-elect Nick Kelsall as a director

74,235,241

99.88

86,792

0.12

13,189

8

To elect James Eyre as a director

74,235,835

99.88

86,198

0.12

13,189

9

To re-appoint BDO LLP as auditor

74,102,414

99.70

223,769

0.30

9,039

10

To authorise the Audit and Risk Committee of the Board to determine the auditor's remuneration

74,318,983

 

99.99

 

6,000

 

0.01

 

10,239

 

11

To authorise the Directors to allot shares up to the specified limit

73,651,879

 

99.09

 

673,104

 

0.91

 

10,239

 

Special Resolutions

12

To empower the Directors to disapply pre-emption rights up to the specified limit.

73,660,317

 

99.11

 

664,666

 

0.89

 

10,239

 

13

To empower the Directors to disapply pre-emption rights up to the specified limit in relation to an acquisition or other specified capital investment

73,660,317

 

99.10

 

667,075

 

0.90

 

7,830

 

14

To grant authority to purchase own shares

74,290,503

 

99.97

 

22,422

 

0.03

 

22,297

 

15

To approve calling of general meetings on not less than 14 clear days' notice.

74,126,709

 

99.73

 

199,263

 

0.27

 

9,250

 

 

*Votes 'For' include those votes giving the Chairman discretion. The votes withheld are not a vote in law and are not counted in the overall voting figures.

The Company's issued share capital consists of 89,255,096 ordinary 10p shares, each of which carries the right to one vote.

Full details of the resolutions were set out in the Notice of Annual General Meeting which is available on the Company's website at www.norcros.com

In accordance with Listing Rule 9.6.2 copies of all the resolutions passed, other than ordinary business, will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism 

ENQUIRIES:

 

Norcros plc

Tel: 01625 547700

Nick Kelsall, Chief Executive Officer

James Eyre, Chief Financial Officer

Hudson Sandler

Tel: 020 7796 4133

Nick Lyon

 

For further information, please visit the Company website:  www.norcros.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGXKLFFLDLBBBL
Date   Source Headline
25th Apr 20247:00 amRNSSale of Johnson Tiles UK
22nd Apr 20242:00 pmRNSInvestor Webinar 7 May 2024
12th Apr 20243:40 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSTrading update
28th Mar 20247:00 amRNSBlock listing Six Monthly Return
28th Mar 20247:00 amRNSVoting Rights and Share Capital Update
1st Mar 20242:09 pmRNSDirectors Share Dealing
23rd Jan 202411:40 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSAppointment of Joint Corporate Broker
22nd Dec 20237:00 amRNSEmployee SAYE awards and director share dealing
1st Dec 20234:35 pmRNSDirector Declaration
23rd Nov 20234:06 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
3rd Nov 20239:00 amRNSInvestor Presentation
12th Oct 20237:00 amRNSTrading Update
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
11th Aug 20234:36 pmRNSDirector's Dealings
26th Jul 20234:50 pmRNSResults of AGM
26th Jul 20231:06 pmRNSDirector's Dealings
26th Jul 20237:00 amRNSAGM Trading Statement
10th Jul 20235:59 pmRNSDirector's Dealings
23rd Jun 20237:00 amRNSAnnual Financial Report and Notice of 2023 AGM
15th Jun 20237:00 amRNSFinal Results
30th May 20237:00 amRNSDirectorate Changes
13th Apr 20237:00 amRNSTrading Update
31st Mar 20237:00 amRNSTotal Voting Rights
28th Mar 20234:16 pmRNSHolding(s) in Company
21st Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20233:19 pmRNSBlock Listing Six Monthly Return
14th Feb 20237:00 amRNSDirectorate Update
30th Jan 20237:00 amRNSCEO Succession
24th Jan 20237:00 amRNSDirectorate Update
15th Dec 20229:40 amRNSBoard Changes
9th Nov 20227:00 amRNSInterim Results
1st Nov 202212:07 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
30th Sep 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Sep 20227:00 amRNSVoting Rights and Share Capital Update
13th Sep 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20229:39 amRNSVoting Rights and Share Capital Update
26th Jul 202212:30 pmRNSHolding(s) in Company
25th Jul 20222:23 pmRNSDirectors' Dealings
19th Jul 20222:05 pmRNSResults of AGM
19th Jul 20221:57 pmRNSDirector Dealings
19th Jul 20227:00 amRNSAGM Trading Statement
15th Jul 20225:08 pmRNSVoting Rights and Share Capital Update
30th Jun 20229:08 amRNSVoting Rights and Share Capital Update
21st Jun 20225:21 pmRNSDirector Declaration
16th Jun 202211:16 amRNSNotice of AGM Annual Report Announcement
14th Jun 20222:25 pmRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.